New York Times, March 6, 2026: FDA’s biologics chief Vinay Prasad is resigning, leaving FDA for the second time. This time his rejection of rare disease treatments angered industry, some rare disease patients, and Members of Congress. But NCHR’s Diana Zuckerman says Prasad’s focus on evidence was welcomed by researchers and advocates who were concerned about FDA’s approval of ineffective treatments.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
FDA’s Hoeg Reportedly Trying To Hire Friend, Fellow Antidepressant Skeptic
BioSpace, March 5, 2026: FDA’s CDER Director Tracy Beth Høeg wants to hire her friend Adam Urato, whose citizen’s petition urges a boxed warning on the risks of SSRIs during pregnancy. Diana Zuckerman and others say Høeg’s work has no nuance and doesn’t want to hear differences of opinion.
Read More »Edwards’ request for broader TAVR Medicare coverage gets pushback
MedTech Dive, January 28, 2026: MedTech Dive quotes public comments to CMS for and against Medicare coverage of TAVR for asymptomatic patients, including NCHR’s and Steve Woloshin’s criticism of the published evidence and medical society support
Read More »Eat Real Food? Yes, but Some Real Food Can Kill You!
The Well News, January 20, 2026: Media coverage of the new food pyramid misses the boat when it focuses on the dietary guide instead of the inaccurate and dangerous “upside-down” pyramid graphic. You should not eat more steak than fruits, vegetables, or fish. The dietary guide is helpful in advising “real food” instead of processed foods, but it was dangerous to remove specific guidelines on how much alcohol is too much.
Read More »5 topics to watch as MDUFA negotiations restart
MedTech Dive, Jan 13, 2025: MedTech outlines 5 key issues as MDUFA negotiations restart, including FDA staffing, device safety and effectiveness, and transparency. The article highlights growing concern from NCHR’s Diana Zuckerman and other patient and consumer groups that safety and effectiveness may receive less attention than faster device approvals.
Read More »